Paternal mosaicism for a COL1A1 dominant mutation (α1 Ser-415) causes recurrent osteogenesis imperfecta
- 1 January 1993
- journal article
- case report
- Published by Hindawi Limited in Human Mutation
- Vol. 2 (3) , 196-204
- https://doi.org/10.1002/humu.1380020308
Abstract
We describe a dominant point mutation in the COL1A1 gene causing extremely severe osteogenesis imperfecta (OI type II/III) which was detected in the dermal fibroblasts of a proband, diagnosed by ultrasonography at 24 weeks of gestation. Type I collagen secretion was reduced and proαl(I) chains were overmodified. The mutation was localised in one COL1A1 allele by chemical cleavage of mismatched bases in normal cDNA/proband's mRNA heteroduplexes, and identified by cloning and sequencing. A G‐to‐A transition which causes the Substitution of Gly‐415 with serine in the a α1(I) triple helical domain was found. The same mutation was detected in the father's spermatozoa and lymphocytes. Mosaicism in the father's germline explains the occurrence in the family of two additional OI pregnancies, which were documented by X‐ray and ultrasound investigations.Keywords
This publication has 22 references indexed in Scilit:
- A dominant mutation in the COL1A1 gene that substitutes glycine for valine causes recurrent lethal osteogenesis imperfectaHuman Genetics, 1992
- Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine ?1(I) 901 substitution in a type-I collagen geneHuman Genetics, 1992
- Substitution of cysteine for glycine at residue 415 of one allele of the alpha 1(I) chain of type I procollagen in type III/IV osteogenesis imperfecta.Journal of Medical Genetics, 1991
- Osteogenesis imperfecta: translation of mutation to phenotype.Journal of Medical Genetics, 1991
- Osteogenesis imperfecta due to recurrent point mutations at CpG dinucleotides in the COL1A1 gene of type I collagenHuman Genetics, 1991
- Anomalous Cysteine in Type I Collagen. Localisation by Chemical Cleavage of the Protein Using 2-Nitro-5-Thiocyanobenzoic Acid and by Mismatch Analysis of cDNA HeteroduplexesMatrix, 1990
- Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.Journal of Clinical Investigation, 1989
- Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneityAmerican Journal of Medical Genetics, 1984
- Nucleotide sequences of complementary deoxyribonucleic acids for the pro.alpha.1 chain of human type I procollagen. Statistical evaluation of structures that are conserved during evolutionBiochemistry, 1983
- Proteolytic enzymes as probes for the triple-helical conformation of procollagenAnalytical Biochemistry, 1981